Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review

Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and posing a significant global health concern. Traditional therapies for UTIs are becoming increasingly ineffective due to rising drug resistance and their tendency to disrupt the h...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoonhee Seo, Md Abdur Rahim, Indrajeet Barman, Mohammed Solayman Hossain, Hanieh Tajdozian, Fatemeh Ghorbanian, Md Sarower Hossen Shuvo, Jiho Choi, Sukyung Kim, Heejo Yang, Ho-Yeon Song
Format: Article
Language:English
Published: Korean Association of Urogenital Tract Infection and Inflammation 2025-04-01
Series:Urogenital Tract Infection
Subjects:
Online Access:http://euti.org/upload/pdf/uti-2448034017.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419254480240640
author Hoonhee Seo
Md Abdur Rahim
Indrajeet Barman
Mohammed Solayman Hossain
Hanieh Tajdozian
Fatemeh Ghorbanian
Md Sarower Hossen Shuvo
Jiho Choi
Sukyung Kim
Heejo Yang
Ho-Yeon Song
author_facet Hoonhee Seo
Md Abdur Rahim
Indrajeet Barman
Mohammed Solayman Hossain
Hanieh Tajdozian
Fatemeh Ghorbanian
Md Sarower Hossen Shuvo
Jiho Choi
Sukyung Kim
Heejo Yang
Ho-Yeon Song
author_sort Hoonhee Seo
collection DOAJ
description Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and posing a significant global health concern. Traditional therapies for UTIs are becoming increasingly ineffective due to rising drug resistance and their tendency to disrupt the host's healthy microbiota, leading to further side effects. Consequently, there is an urgent need to develop alternative therapeutic agents that differ from conventional regimens and have fewer or no side effects. In this context, microbiome therapeutics offer a promising solution, given their demonstrated efficacy against various infectious diseases. Advances in scientific technology, particularly next-generation sequencing, have deepened our understanding of urinary microbiome dynamics, revealing a complex interplay within the urobiome that influences the onset and progression of UTIs. Uropathogenic bacteria do not solely cause UTIs; shifts in the composition of the urinary microbiome and interactions within the microbial community, known as host-microbiota interactions, also play a significant role. Although recent studies underscore the potential of targeting the urinary microbiome to manage UTIs and related complications, this field is still emerging and faces numerous regulatory and technical challenges. Further in-depth and comprehensive research is required to advance this pioneering concept into clinical practice.
format Article
id doaj-art-1d8449a151fc4752ac1e5cc5778fb7bc
institution Kabale University
issn 2465-8243
2465-8510
language English
publishDate 2025-04-01
publisher Korean Association of Urogenital Tract Infection and Inflammation
record_format Article
series Urogenital Tract Infection
spelling doaj-art-1d8449a151fc4752ac1e5cc5778fb7bc2025-08-20T03:32:11ZengKorean Association of Urogenital Tract Infection and InflammationUrogenital Tract Infection2465-82432465-85102025-04-0120141610.14777/uti.2448034017430Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative ReviewHoonhee Seo0Md Abdur Rahim1Indrajeet Barman2Mohammed Solayman Hossain3Hanieh Tajdozian4Fatemeh Ghorbanian5Md Sarower Hossen Shuvo6Jiho Choi7Sukyung Kim8Heejo Yang9Ho-Yeon Song10 Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Next-Generation Microbiome Training Center, Soonchunhyang University, Asan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, Korea Department of Urology, School of Medicine, Soonchunhyang University, Cheonan, Korea Human Microbiome Medical Research Center (HMㆍMRC), School of Medicine, Soonchunhyang University, Asan, KoreaUrinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and posing a significant global health concern. Traditional therapies for UTIs are becoming increasingly ineffective due to rising drug resistance and their tendency to disrupt the host's healthy microbiota, leading to further side effects. Consequently, there is an urgent need to develop alternative therapeutic agents that differ from conventional regimens and have fewer or no side effects. In this context, microbiome therapeutics offer a promising solution, given their demonstrated efficacy against various infectious diseases. Advances in scientific technology, particularly next-generation sequencing, have deepened our understanding of urinary microbiome dynamics, revealing a complex interplay within the urobiome that influences the onset and progression of UTIs. Uropathogenic bacteria do not solely cause UTIs; shifts in the composition of the urinary microbiome and interactions within the microbial community, known as host-microbiota interactions, also play a significant role. Although recent studies underscore the potential of targeting the urinary microbiome to manage UTIs and related complications, this field is still emerging and faces numerous regulatory and technical challenges. Further in-depth and comprehensive research is required to advance this pioneering concept into clinical practice.http://euti.org/upload/pdf/uti-2448034017.pdfurinary tract infectionsmicrobiome therapeuticsurobiomeurinary microbiome dynamicshost-microbiota interaction
spellingShingle Hoonhee Seo
Md Abdur Rahim
Indrajeet Barman
Mohammed Solayman Hossain
Hanieh Tajdozian
Fatemeh Ghorbanian
Md Sarower Hossen Shuvo
Jiho Choi
Sukyung Kim
Heejo Yang
Ho-Yeon Song
Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
Urogenital Tract Infection
urinary tract infections
microbiome therapeutics
urobiome
urinary microbiome dynamics
host-microbiota interaction
title Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
title_full Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
title_fullStr Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
title_full_unstemmed Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
title_short Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
title_sort emerging insights into microbiome therapeutics for urinary tract infections a narrative review
topic urinary tract infections
microbiome therapeutics
urobiome
urinary microbiome dynamics
host-microbiota interaction
url http://euti.org/upload/pdf/uti-2448034017.pdf
work_keys_str_mv AT hoonheeseo emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT mdabdurrahim emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT indrajeetbarman emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT mohammedsolaymanhossain emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT haniehtajdozian emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT fatemehghorbanian emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT mdsarowerhossenshuvo emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT jihochoi emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT sukyungkim emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT heejoyang emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview
AT hoyeonsong emerginginsightsintomicrobiometherapeuticsforurinarytractinfectionsanarrativereview